You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Models of Care for Cancer Survivorship

Patient Population

Adults without evidence of disease after primary, curative treatment for any stage of cancer comprise the target population. Both clinical outcomes (recurrence, surveillance) and quality of life (QoL) outcomes (quality of life, patient satisfaction) from follow-up strategies reported for patients at all levels of risk of recurrence are of interest.

Intended Guideline Users

  1. Health professionals who are responsible for the care of adults with cancer who are clinically disease free after receiving curative treatment.
  2. Health professionals engaged in the care of adults with cancer who are clinically disease free after receiving curative treatment and who would make referrals to the appropriate care team.
  3. Administrative and system leaders responsible for implementing high-quality evidence informed survivorship services for adults with cancer who are clinically disease free after receiving curative treatment.

Research Question(s)

  1. What are the models described in the literature for the follow-up care of adults with cancer who have completed treatment and are clinically disease free?
  2. Are certain models favoured for survivors of specific cancer types in terms of the following:
    1. Clinical outcomes (e.g., surveillance, recurrence)
    2. Survivor quality of life outcomes (e.g., quality of life, patient satisfaction)
Modality: 

Primary Care

Psychosocial Oncology Care

Nursing Care

PEBC: 

PEBC

Guideline Identifier: 

26-1

Cancer Continuum: 

Survivorship

Cancer Type: 

All

Type of Content: 

Guidelines & Advice

Clinical

Authors:  J. Sussman L.H. Souter E. Grunfeld D. Howell C. Gage S. Keller-Olaman M. Brouwers Universal Date:  2017-03-28 00:00:00